8-K: U.S. Physical Therapy Reports Q1 2026 Results, Reaffirms Guidance

U.S. Physical Therapy, Inc. hosted a conference call to discuss its first quarter 2026 results, reporting revenue growth and reaffirming full-year guidance.

Summary

• U.S. Physical Therapy, Inc. reported first quarter 2026 results, with total revenue reaching $198 million, a 7.9% increase year-over-year.
• Physical therapy revenue grew 7.2% to $168 million, with same-store revenue up 2.5%.
• Injury prevention services revenue increased by 11.8% to $31 million.
• The company reaffirmed its full-year 2026 Adjusted EBITDA guidance of $102 million to $106 million.
• Key initiatives include semi-virtualization of front desks, AI-assisted documentation, re-engagement with remote therapeutic monitoring, expansion of cash-based programs, and strategic hospital system alliances.
• The company completed the renegotiation of its five-year credit facility, increasing capacity to $450 million.
• Two acquisitions were completed in Q1 2026: an eight-clinic therapy partnership and an industrial injury prevention business.
• The company repurchased equity in two partnerships for over $14 million.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, with solid revenue growth, reaffirmation of guidance, and strategic initiatives progressing, though some margin pressures and a decrease in net income were noted.

Positives

• Total revenue increased by 7.9% to $198 million in Q1 2026.
• Physical therapy revenue increased by 7.2% to $168 million, with same-store revenue up 2.5%.
• Injury prevention services revenue increased by 11.8% to $31 million.
• Net patient revenue per visit increased to $106.49, driven by a 3.4% increase in commercial rates.
• Adjusted EBITDA increased by $0.7 million to $20.2 million in Q1 2026.
• The company reaffirmed its full-year 2026 Adjusted EBITDA guidance of $102 million to $106 million.
• The credit facility was upsized to $450 million, providing increased capacity for growth.
• Employee turnover is at a low of sub-18%, the lowest since measurement began.

Negatives

• Adjusted physical therapy margin decreased to 16.1% in Q1 2026 from 16.8% in Q1 2025.
• Adjusted corporate expense as a rate to revenue increased to 8.8% in Q1 2026 from 8.5% in Q1 2025.
• Interest expense increased to $2.8 million in Q1 2026 from $2.3 million in Q1 2025.
• Income tax rate increased to 32.3% in Q1 2026 from 28.1% in Q1 2025.
• Net income attributable to USPH shareholders was $5.0 million in Q1 2026, down from $9.9 million in Q1 2025.
• GAAP loss per share was $0.12 in Q1 2026, compared to earnings per share of $0.80 in Q1 2025.
• A loss on change in fair value of contingent earn-out considerations of $2.0 million was recorded in Q1 2026.
• Medicaid rates saw a small drop on a blended basis.

Risks

• Forward-looking statements involve risks and uncertainties, including changes in Medicare rules, reimbursement rates, and patient co-pays.
• Compliance with federal and state laws regarding patient privacy and the corporate practice of medicine.
• Competitive, economic, or reimbursement conditions may require clinic reorganizations or closures.
• Termination of hospital affiliation arrangements could adversely impact revenue.
• Future public health crises, epidemics, or pandemics.
• Debt and financial obligations could affect financial condition and ability to obtain future financing.
• Changes resulting from national healthcare reform.
• Cyber-attacks on information technology systems could lead to legal action and reputational harm.

Future Outlook

The company reaffirmed its full-year 2026 Adjusted EBITDA guidance of $102 million to $106 million, expressing confidence in achieving these targets through ongoing initiatives, continued ramp-up of visits, and strategic growth opportunities.

Management Comments

• Chris Reading: 'These initiatives are on track, and we believe will produce the results we have discussed as the year progresses. This in combination with continuing ramp up of visits across the Company gives us the confidence to reaffirm our previous guidance.'
• Chris Reading: 'We lost over 31,000 visits to weather, which impacts not just revenue, but the vast majority of our highest paid people we had to pay to sit at home during these weather events, which is a drag on margins.'
• Jason Curtis: 'Our first quarter results were in line with our expectations, and we expect the impact of the 2026 objectives, which Chris discussed, to ramp up throughout the course of the year.'
• Chris Reading on hospital partnerships: 'There are bigger opportunities than NYU. Part of the reason that the impact to us is smaller, even on the big NYU opportunity, is we only own 50% of that business.'

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy's focus on expanding cash-based programs and strategic hospital alliances aligns with industry trends towards value-based care and consolidation in the fragmented physical therapy market.

Comparison to Industry Standards

• The U.S. rehabilitation market is valued at over $40 billion, with no single company holding more than 10% market share, indicating a highly fragmented landscape where U.S. Physical Therapy is a leading consolidator.
• The company's strategy of driving organic growth through de novo clinics and strategic acquisitions is a common approach for large players in the physical therapy sector seeking to expand their footprint.
• The focus on improving patient outcomes and reducing overall treatment costs, as demonstrated by the comparison of hip replacement surgery costs with and without physical therapy, aligns with industry-wide efforts to prove the ROI of rehabilitation services.

Stakeholder Impact

• Shareholders: Reaffirmation of guidance and strategic initiatives suggest continued focus on growth and value creation.
• Employees: Focus on clinician retention and AI technology aims to improve efficiency and patient interface.
• Patients: Initiatives like AI documentation and cash-based programs aim to enhance patient care and access.
• Partners: Expansion of cash-based programs and strategic hospital alliances offer growth opportunities.

Next Steps

• Continue ramp-up of visits across the company.
• Implement semi-virtualization of front desks.
• Deploy AI-assisted ambient listening documentation technology.
• Re-engage with remote therapeutic monitoring for Medicare population.
• Expand cash-based programs.
• Continue efforts to create opportunities with large hospital systems.
• Roll out facilities across NYU and Gulf Coast hospital opportunities.
• Complete Workday ERP implementation by the beginning of 2027.

Key Dates

Recommendation

The company demonstrated expected results for the quarter, reaffirmed its full-year guidance, and is executing on strategic growth initiatives including acquisitions and hospital partnerships. However, a slight decrease in net income and pressure on physical therapy margins warrant a 'hold' recommendation pending further clarity on the impact of these initiatives and margin recovery.

Keywords

physical therapy, outpatient clinics, injury prevention, healthcare services, revenue growth, acquisitions, credit facility, EBITDA